GSK840 (Synonyms: GSK'840) |
カタログ番号GC34605 |
GSK840 (GSK'840) は、受容体相互作用タンパク質キナーゼ 3 (RIP3 または RIPK3) 阻害剤であり、RIP3 キナーゼ ドメインに 0.9 nM の IC50 で結合し、0.3 nM の IC50 でキナーゼ活性を阻害します 。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2361146-30-5
Sample solution is provided at 25 µL, 10mM.
GSK840 (GSK’840) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 0.9 nM, and inhibits kinase activity with an IC50 of 0.3 nM[1]. IC50: 0.3 nM (RIP3)[1]
Reference:
[1]. Mandal P, et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell. 2014 Nov 20;56(4):481-95.
Average Rating: 5
(Based on Reviews and 24 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *